The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era: Role of DLI in Post-HCT Relapse for CML in the TKI Era

  • Sarah Schmidt
  • , Ying Liu
  • , Zhen Huan Hu
  • , Kirsten M. Williams
  • , Hillard M. Lazarus
  • , Ravi Vij
  • , Mohamed A. Kharfan-Dabaja
  • , Guillermo Ortí
  • , Peter H. Wiernik
  • , Daniel Weisdorf
  • , Rammurti T. Kamble
  • , Roger Herzig
  • , Baldeep Wirk
  • , Jan Cerny
  • , Ulrike Bacher
  • , Naeem A. Chaudhri
  • , Sunita Nathan
  • , Nosha Farhadfar
  • , Mahmoud Aljurf
  • , Usama Gergis
  • Jeffrey Szer, Sachiko Seo, Jack W. Hsu, Richard F. Olsson, Dipnarine Maharaj, Biju George, Gerhard C. Hildebrandt, Vaibhav Agrawal, Taiga Nishihori, Hisham Abdel-Azim, Edwin Alyea, Uday Popat, Ronald Sobecks, Bart L. Scott, Jennifer Holter Chakrabarty, Wael Saber

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1137-1143
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume26
Issue number6
DOIs
StatePublished - Jun 2020
Externally publishedYes

ASJC Scopus Subject Areas

  • Hematology
  • Transplantation

Keywords

  • Chronic myeloid leukemia
  • Donor lymphocyte infusion
  • Hematopoietic cell transplantation
  • Tyrosine kinase inhibitor

Cite this